Thus, increased AR expression in melanoma cells subverts the transcriptional response of melanoma cells to BRAF inhibition, with suppression of pro-apoptotic, immunomodulatory, and antigen presentation pathways and enhancement of pathways implicated in tumor progression and BRAFi resistance. The gene discussed is BRAF; the disease is neoplasm.